Elisa Pagnin Selected Research

oxidized low density lipoprotein

6/2014	Molecular biology based assessment of green tea effects on oxidative stress and cardiac remodelling in dialysis patients.
12/2011	Effect of olmesartan on oxidative stress in hypertensive patients: mechanistic support to clinical trials derived evidence.
2/2011	Molecular biology-based assessment of vitamin E-coated dialyzer effects on oxidative stress, inflammation, and vascular remodeling.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Elisa Pagnin Research Topics

Disease

15	Hypertension (High Blood Pressure) 02/2023 - 10/2002
9	Gitelman Syndrome 08/2018 - 01/2003
6	Chronic Kidney Failure (Chronic Renal Failure) 01/2020 - 01/2003
6	Cardiovascular Diseases (Cardiovascular Disease) 06/2014 - 02/2006
5	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 03/2024 - 10/2015
4	Hypotension (Low Blood Pressure) 02/2014 - 01/2003
3	Fibrosis (Cirrhosis) 01/2016 - 04/2004
3	Metabolic Syndrome (Dysmetabolic Syndrome X) 10/2015 - 02/2011
3	Atherosclerosis 12/2011 - 10/2004
3	Inflammation (Inflammations) 02/2011 - 06/2006
2	Disease Progression 10/2023 - 01/2003
2	Neoplasms (Cancer) 10/2021 - 01/2016
2	Atrial Fibrillation 01/2020 - 01/2019
2	Chronic Renal Insufficiency 01/2019 - 03/2016
2	Fabry Disease (Fabry's Disease) 11/2018 - 01/2018
2	Type 2 Diabetes Mellitus (MODY) 04/2016 - 04/2003
2	Hypertrophy 03/2016 - 06/2014
2	Insulin Resistance 10/2015 - 10/2013
2	Heart Failure 03/2015 - 03/2008
2	Rare Diseases (Rare Disease) 10/2013 - 07/2012
2	Vascular Remodeling 12/2011 - 02/2011
1	Alkalosis 02/2023
1	Lymphoid Leukemia 10/2021
1	Lysosomal Storage Diseases (Lysosomal Storage Disease) 11/2018
1	Large Granular Lymphocytic Leukemia 09/2017
1	Neutropenia 09/2017
1	Diabetic Nephropathies (Diabetic Nephropathy) 04/2016
1	Left Ventricular Hypertrophy (Ventricular Hypertrophy, Left) 03/2016
1	Obesity 10/2015
1	Body Weight (Weight, Body) 10/2015
1	Lung Diseases (Lung Disease) 03/2015
1	Coronary Disease (Coronary Heart Disease) 03/2015
1	Bartter Syndrome (Syndrome, Bartter) 02/2014

Drug/Important Bio-Agent (IBA)

12	Angiotensin IIIBA 01/2016 - 01/2003
10	Proteins (Proteins, Gene)FDA Link 01/2016 - 09/2005
9	rho-Associated KinasesIBA 01/2020 - 10/2004
5	4- ethoxymethylene- 2- phenyl- 2- oxazoline- 5- one (phOx)IBA 06/2014 - 04/2003
4	CytokinesIBA 01/2018 - 06/2006
4	Nitric Oxide (Nitrogen Monoxide)FDA Link 01/2018 - 10/2002
4	Heme Oxygenase-1IBA 04/2016 - 07/2006
3	EnzymesIBA 11/2018 - 09/2010
3	oxidized low density lipoproteinIBA 06/2014 - 02/2011
3	NADPH Oxidases (NAD(P)H oxidase)IBA 09/2008 - 04/2003
2	Immunoglobulin Heavy Chains (Immunoglobulin Heavy Chain)IBA 03/2024 - 10/2019
2	Vitamin E FDA LinkGeneric 01/2019 - 02/2011
2	Reactive Oxygen Species (Oxygen Radicals)IBA 10/2015 - 02/2006
2	Glucose (Dextrose)FDA LinkGeneric 10/2015 - 09/2010
2	LDL CholesterolIBA 03/2015 - 02/2006
2	Type 1 Angiotensin ReceptorIBA 02/2014 - 10/2013
2	Messenger RNA (mRNA)IBA 02/2014 - 09/2005
2	Heme Oxygenase (Decyclizing) (Heme Oxygenase)IBA 01/2014 - 02/2011
2	AntioxidantsIBA 01/2014 - 12/2011
2	erucylphosphocholineIBA 07/2012 - 09/2011
2	GTP-Binding Proteins (G-Protein)IBA 05/2008 - 08/2004
2	C-Reactive ProteinIBA 06/2006 - 04/2006
2	Superoxides (Superoxide)IBA 03/2005 - 04/2003
2	AldosteroneIBA 04/2004 - 01/2003
1	CalpainIBA 10/2023
1	Focal Adhesion Protein-Tyrosine KinasesIBA 10/2023
1	CortactinIBA 10/2023
1	SodiumIBA 02/2023
1	Transcription Factors (Transcription Factor)IBA 10/2021
1	ibrutinibIBA 10/2021
1	Heat-Shock Proteins (Heat-Shock Protein)IBA 10/2021
1	Gap Junction alpha-5 ProteinIBA 01/2020
1	HDL LipoproteinsIBA 01/2019
1	GalactosidasesIBA 11/2018
1	globotriaosylceramide (globotriosylceramide)IBA 11/2018
1	Sodium Chloride FDA LinkGeneric 08/2018
1	SymportersIBA 08/2018
1	Fas Ligand Protein (Fas Ligand)IBA 09/2017
1	Cadherins (E-Cadherin)IBA 01/2016
1	Angiotensin Receptors (Angiotensin II Receptor)IBA 01/2016
1	Endothelin-1 (Endothelin 1)IBA 01/2016
1	NADPH Oxidase 4IBA 12/2015
1	Oxygen (Dioxygen)IBA 12/2015
1	Insulin (Novolin)FDA Link 10/2015
1	LeptinIBA 10/2015
1	HDL CholesterolIBA 03/2015
1	LipidsIBA 03/2015
1	AdipokinesIBA 06/2014
1	Retinol-Binding Proteins (Retinoid Binding Proteins)IBA 06/2014
1	Capsules (Microcapsules)IBA 06/2014
1	Calcitonin Gene-Related PeptideIBA 01/2014
1	Sirtuin 1IBA 10/2013
1	AngiotensinsIBA 07/2012
1	Angiotensin II Type 1 Receptor BlockersIBA 12/2011
1	olmesartanIBA 12/2011
1	LDL Lipoproteins (beta Lipoproteins)IBA 12/2011
1	ImmunosorbentsIBA 02/2011
1	TOR Serine-Threonine KinasesIBA 02/2011
1	Nitric Oxide Synthase (NO Synthase)IBA 02/2011
1	Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA 02/2011
1	Bicarbonates (Hydrogen Carbonate)IBA 02/2011
1	Plasminogen InactivatorsIBA 02/2011

Therapy/Procedure

3	Therapeutics 12/2023 - 09/2015
2	Renal Dialysis (Hemodialysis) 01/2019 - 02/2011
1	Enzyme Replacement Therapy 01/2018
1	Time-to-Treatment 10/2015
1	Hemodiafiltration 02/2011